Baricitinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Baricitinib and local guidelines before prescribing.

JAK inhibitor

Mechanism

JAK1 and JAK2 inhibitor.

Uses

Rheumatoid arthritis, atopic dermatitis, alopecia areata, COVID-19 (selected).

Dosing

Side effects

Infections, raised lipids, cytopenias, VTE, MACE, herpes zoster.

Interactions

Probenecid raises levels.

Contraindications and cautions

Active infection, pregnancy

Monitoring

FBC, LFT, lipids

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

MHRA JAK caution groups; reduce dose in renal impairment.

More from the textbook: uses, cautions and other points
Where it is discussed in the book